- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.
The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.
According to our latest study, the global Celecoxib market size was valued at USD 1308.1 million in 2022 and is forecast to a readjusted size of USD 2247.5 million by 2029 with a CAGR of 8.0% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Data show that more than 400 million people worldwide are currently affected by joint diseases.
The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.
The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.
At present, the burden of chronic diseases will increase by 40% due to the aging of the population.
As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.
Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.
At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.
At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.
It accounted for 63.39% of the global market in 2019.
As of 2019, China relies entirely on Pfizer for celecoxib imports.
Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.
This report is a detailed and comprehensive analysis for global Celecoxib market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Celecoxib market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Celecoxib market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Celecoxib
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Celecoxib market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc, Teva, Mylan, Apotex and Lupin and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Celecoxib market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
50mg
100mg
200mg
400mg
Market segment by Application
Rheumatoid arthritis
osteoarthritis
Acute pain
Musculoskeletal pain
Other diseases
Major players covered
Pfizer Inc
Teva
Mylan
Apotex
Lupin
Hengrui Medicine
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Celecoxib product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celecoxib, with price, sales, revenue and global market share of Celecoxib from 2018 to 2023.
Chapter 3, the Celecoxib competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Celecoxib market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celecoxib.
Chapter 14 and 15, to describe Celecoxib sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Celecoxib
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Celecoxib Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 50mg
1.3.3 100mg
1.3.4 200mg
1.3.5 400mg
1.4 Market Analysis by Application
1.4.1 Overview: Global Celecoxib Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Rheumatoid arthritis
1.4.3 osteoarthritis
1.4.4 Acute pain
1.4.5 Musculoskeletal pain
1.4.6 Other diseases
1.5 Global Celecoxib Market Size & Forecast
1.5.1 Global Celecoxib Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Celecoxib Sales Quantity (2018-2029)
1.5.3 Global Celecoxib Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer Inc
2.1.1 Pfizer Inc Details
2.1.2 Pfizer Inc Major Business
2.1.3 Pfizer Inc Celecoxib Product and Services
2.1.4 Pfizer Inc Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Inc Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Celecoxib Product and Services
2.2.4 Teva Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Teva Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Celecoxib Product and Services
2.3.4 Mylan Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Mylan Recent Developments/Updates
2.4 Apotex
2.4.1 Apotex Details
2.4.2 Apotex Major Business
2.4.3 Apotex Celecoxib Product and Services
2.4.4 Apotex Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Apotex Recent Developments/Updates
2.5 Lupin
2.5.1 Lupin Details
2.5.2 Lupin Major Business
2.5.3 Lupin Celecoxib Product and Services
2.5.4 Lupin Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lupin Recent Developments/Updates
2.6 Hengrui Medicine
2.6.1 Hengrui Medicine Details
2.6.2 Hengrui Medicine Major Business
2.6.3 Hengrui Medicine Celecoxib Product and Services
2.6.4 Hengrui Medicine Celecoxib Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Hengrui Medicine Recent Developments/Updates
3 Competitive Environment: Celecoxib by Manufacturer
3.1 Global Celecoxib Sales Quantity by Manufacturer (2018-2023)
3.2 Global Celecoxib Revenue by Manufacturer (2018-2023)
3.3 Global Celecoxib Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Celecoxib by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Celecoxib Manufacturer Market Share in 2022
3.4.2 Top 6 Celecoxib Manufacturer Market Share in 2022
3.5 Celecoxib Market: Overall Company Footprint Analysis
3.5.1 Celecoxib Market: Region Footprint
3.5.2 Celecoxib Market: Company Product Type Footprint
3.5.3 Celecoxib Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Celecoxib Market Size by Region
4.1.1 Global Celecoxib Sales Quantity by Region (2018-2029)
4.1.2 Global Celecoxib Consumption Value by Region (2018-2029)
4.1.3 Global Celecoxib Average Price by Region (2018-2029)
4.2 North America Celecoxib Consumption Value (2018-2029)
4.3 Europe Celecoxib Consumption Value (2018-2029)
4.4 Asia-Pacific Celecoxib Consumption Value (2018-2029)
4.5 South America Celecoxib Consumption Value (2018-2029)
4.6 Middle East and Africa Celecoxib Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Celecoxib Sales Quantity by Type (2018-2029)
5.2 Global Celecoxib Consumption Value by Type (2018-2029)
5.3 Global Celecoxib Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Celecoxib Sales Quantity by Application (2018-2029)
6.2 Global Celecoxib Consumption Value by Application (2018-2029)
6.3 Global Celecoxib Average Price by Application (2018-2029)
7 North America
7.1 North America Celecoxib Sales Quantity by Type (2018-2029)
7.2 North America Celecoxib Sales Quantity by Application (2018-2029)
7.3 North America Celecoxib Market Size by Country
7.3.1 North America Celecoxib Sales Quantity by Country (2018-2029)
7.3.2 North America Celecoxib Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Celecoxib Sales Quantity by Type (2018-2029)
8.2 Europe Celecoxib Sales Quantity by Application (2018-2029)
8.3 Europe Celecoxib Market Size by Country
8.3.1 Europe Celecoxib Sales Quantity by Country (2018-2029)
8.3.2 Europe Celecoxib Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Celecoxib Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Celecoxib Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Celecoxib Market Size by Region
9.3.1 Asia-Pacific Celecoxib Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Celecoxib Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Celecoxib Sales Quantity by Type (2018-2029)
10.2 South America Celecoxib Sales Quantity by Application (2018-2029)
10.3 South America Celecoxib Market Size by Country
10.3.1 South America Celecoxib Sales Quantity by Country (2018-2029)
10.3.2 South America Celecoxib Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Celecoxib Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Celecoxib Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Celecoxib Market Size by Country
11.3.1 Middle East & Africa Celecoxib Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Celecoxib Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Celecoxib Market Drivers
12.2 Celecoxib Market Restraints
12.3 Celecoxib Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Celecoxib and Key Manufacturers
13.2 Manufacturing Costs Percentage of Celecoxib
13.3 Celecoxib Production Process
13.4 Celecoxib Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Celecoxib Typical Distributors
14.3 Celecoxib Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Celecoxib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Celecoxib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc Major Business
Table 5. Pfizer Inc Celecoxib Product and Services
Table 6. Pfizer Inc Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Inc Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Celecoxib Product and Services
Table 11. Teva Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Celecoxib Product and Services
Table 16. Mylan Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Mylan Recent Developments/Updates
Table 18. Apotex Basic Information, Manufacturing Base and Competitors
Table 19. Apotex Major Business
Table 20. Apotex Celecoxib Product and Services
Table 21. Apotex Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Apotex Recent Developments/Updates
Table 23. Lupin Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Major Business
Table 25. Lupin Celecoxib Product and Services
Table 26. Lupin Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lupin Recent Developments/Updates
Table 28. Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 29. Hengrui Medicine Major Business
Table 30. Hengrui Medicine Celecoxib Product and Services
Table 31. Hengrui Medicine Celecoxib Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Hengrui Medicine Recent Developments/Updates
Table 33. Global Celecoxib Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Celecoxib Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Celecoxib Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Celecoxib, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Celecoxib Production Site of Key Manufacturer
Table 38. Celecoxib Market: Company Product Type Footprint
Table 39. Celecoxib Market: Company Product Application Footprint
Table 40. Celecoxib New Market Entrants and Barriers to Market Entry
Table 41. Celecoxib Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Celecoxib Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Celecoxib Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Celecoxib Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Celecoxib Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Celecoxib Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Celecoxib Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Celecoxib Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Celecoxib Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Celecoxib Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Celecoxib Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Celecoxib Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Celecoxib Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Celecoxib Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Celecoxib Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Celecoxib Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Celecoxib Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Celecoxib Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Celecoxib Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Celecoxib Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Celecoxib Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Celecoxib Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Celecoxib Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Celecoxib Raw Material
Table 101. Key Manufacturers of Celecoxib Raw Materials
Table 102. Celecoxib Typical Distributors
Table 103. Celecoxib Typical Customers
List of Figures
Figure 1. Celecoxib Picture
Figure 2. Global Celecoxib Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Celecoxib Consumption Value Market Share by Type in 2022
Figure 4. 50mg Examples
Figure 5. 100mg Examples
Figure 6. 200mg Examples
Figure 7. 400mg Examples
Figure 8. Global Celecoxib Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Celecoxib Consumption Value Market Share by Application in 2022
Figure 10. Rheumatoid arthritis Examples
Figure 11. osteoarthritis Examples
Figure 12. Acute pain Examples
Figure 13. Musculoskeletal pain Examples
Figure 14. Other diseases Examples
Figure 15. Global Celecoxib Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Celecoxib Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Celecoxib Sales Quantity (2018-2029) & (K Units)
Figure 18. Global Celecoxib Average Price (2018-2029) & (US$/Unit)
Figure 19. Global Celecoxib Sales Quantity Market Share by Manufacturer in 2022
Figure 20. Global Celecoxib Consumption Value Market Share by Manufacturer in 2022
Figure 21. Producer Shipments of Celecoxib by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 22. Top 3 Celecoxib Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Top 6 Celecoxib Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Global Celecoxib Sales Quantity Market Share by Region (2018-2029)
Figure 25. Global Celecoxib Consumption Value Market Share by Region (2018-2029)
Figure 26. North America Celecoxib Consumption Value (2018-2029) & (USD Million)
Figure 27. Europe Celecoxib Consumption Value (2018-2029) & (USD Million)
Figure 28. Asia-Pacific Celecoxib Consumption Value (2018-2029) & (USD Million)
Figure 29. South America Celecoxib Consumption Value (2018-2029) & (USD Million)
Figure 30. Middle East & Africa Celecoxib Consumption Value (2018-2029) & (USD Million)
Figure 31. Global Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 32. Global Celecoxib Consumption Value Market Share by Type (2018-2029)
Figure 33. Global Celecoxib Average Price by Type (2018-2029) & (US$/Unit)
Figure 34. Global Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 35. Global Celecoxib Consumption Value Market Share by Application (2018-2029)
Figure 36. Global Celecoxib Average Price by Application (2018-2029) & (US$/Unit)
Figure 37. North America Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 38. North America Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 39. North America Celecoxib Sales Quantity Market Share by Country (2018-2029)
Figure 40. North America Celecoxib Consumption Value Market Share by Country (2018-2029)
Figure 41. United States Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Canada Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Mexico Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Europe Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 45. Europe Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 46. Europe Celecoxib Sales Quantity Market Share by Country (2018-2029)
Figure 47. Europe Celecoxib Consumption Value Market Share by Country (2018-2029)
Figure 48. Germany Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. France Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. United Kingdom Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Russia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Italy Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Asia-Pacific Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 54. Asia-Pacific Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 55. Asia-Pacific Celecoxib Sales Quantity Market Share by Region (2018-2029)
Figure 56. Asia-Pacific Celecoxib Consumption Value Market Share by Region (2018-2029)
Figure 57. China Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Japan Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Korea Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. India Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Southeast Asia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Australia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. South America Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 64. South America Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 65. South America Celecoxib Sales Quantity Market Share by Country (2018-2029)
Figure 66. South America Celecoxib Consumption Value Market Share by Country (2018-2029)
Figure 67. Brazil Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Argentina Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Middle East & Africa Celecoxib Sales Quantity Market Share by Type (2018-2029)
Figure 70. Middle East & Africa Celecoxib Sales Quantity Market Share by Application (2018-2029)
Figure 71. Middle East & Africa Celecoxib Sales Quantity Market Share by Region (2018-2029)
Figure 72. Middle East & Africa Celecoxib Consumption Value Market Share by Region (2018-2029)
Figure 73. Turkey Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Egypt Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Saudi Arabia Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. South Africa Celecoxib Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. Celecoxib Market Drivers
Figure 78. Celecoxib Market Restraints
Figure 79. Celecoxib Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Celecoxib in 2022
Figure 82. Manufacturing Process Analysis of Celecoxib
Figure 83. Celecoxib Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
